Multispecific antigen-binding molecule having blood coagulation factor VIII (FVIII) cofactor function-substituting activity, and pharmaceutical formulation containing said molecule as active ingredient
The inventor has succeeded in discovering a bispecific antibody that raises FVIII cofactor function-substituting activity without raising FIX activated inhibitory activity.